ARROWHEAD PHARMACEUTICALS INC
NASDAQ: ARWR (Arrowhead Pharmaceuticals, Inc.)
Kemas kini terakhir: 1 jam lalu86.73
-0.38 (-0.44%)
| Penutupan Terdahulu | 87.11 |
| Buka | 86.77 |
| Jumlah Dagangan | 1,104,361 |
| Purata Dagangan (3B) | 2,061,053 |
| Modal Pasaran | 12,216,529,920 |
| Harga / Pendapatan (P/E Ke hadapan) | 111.11 |
| Harga / Jualan (P/S) | 18.28 |
| Harga / Buku (P/B) | 26.44 |
| Julat 52 Minggu |
| Margin Keuntungan | -26.41% |
| Margin Operasi (TTM) | 70.24% |
| EPS Cair (TTM) | -1.24 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -29.60% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 108.23% |
| Nisbah Semasa (MRQ) | 5.15 |
| Aliran Tunai Operasi (OCF TTM) | 61.15 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -6.46 M |
| Pulangan Atas Aset (ROA TTM) | -5.86% |
| Pulangan Atas Ekuiti (ROE TTM) | -26.22% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Menaik |
| Biotechnology (Global) | Bercampur | Menaik | |
| Stok | Arrowhead Pharmaceuticals, Inc. | Bercampur | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | -1.5 |
| Volatiliti Harga | -0.5 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | 2.0 |
| Purata | 0.00 |
|
Arrowhead Pharmaceuticals Inc is a commercial-stage pharmaceutical company. It is focused on the development of medicines for diseases associated with genetic abnormalities or protein overproduction. The company develops potential RNAi therapies designed to inhibit the expression of genes known to trigger diseases. Its portfolio includes potential drugs targeting Cardiometabolic, Neuromuscular, Pulmonary, Liver, and other diseases. The company also develops RNAi products and clinical candidates designed to target different cell types within the body. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Growth |
| % Dimiliki oleh Orang Dalam | 13.02% |
| % Dimiliki oleh Institusi | 77.19% |
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| OLUKOTUN ADEOYE Y | - | 87.90 | -2,000 | -175,800 |
| PERRY MICHAEL S | - | 87.90 | -11,600 | -1,019,640 |
| Jumlah Keseluruhan Kuantiti Bersih | -13,600 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | -1,195,440 | |||
| Purata Pembelian Keseluruhan ($) | - | |||
| Purata Jualan Keseluruhan ($) | 87.90 | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| PERRY MICHAEL S | Pengarah | 18 Aug 2026 | Jual (-) | 11,600 | 87.90 | 1,019,640 |
| OLUKOTUN ADEOYE Y | Pengarah | 18 Aug 2026 | Jual (-) | 2,000 | 87.90 | 175,800 |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |